List of works by Catherine Abrial

A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN)

scientific article published on 01 March 2008

Achieving higher pathological complete response rates in HER-2-positive patients with induction chemotherapy without trastuzumab in operable breast cancer.

scientific article published on April 2007

BCRP and P-gp relay overexpression in triple negative basal-like breast cancer cell line: a prospective role in resistance to Olaparib.

scientific article published on 3 August 2015

Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?

scientific article published on 04 March 2015

Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy.

scientific article

Changes in and prognostic value of hormone receptor status in a series of operable breast cancer patients treated with neoadjuvant chemotherapy

scientific article published on 01 June 2007

Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patients

scientific article published on 02 May 2009

Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer.

scientific article published on 10 June 2008

Dietary methionine restriction with FOLFOX regimen as first line therapy of metastatic colorectal cancer: a feasibility study.

scientific article published on 26 April 2010

Does regional lymph node irradiation improve the outcome of N0 and pN0 breast cancer?

scientific article published on 01 February 2010

ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis

scientific article

Everolimus in Metastatic Breast Cancer: Clinical Experience as a Late Treatment Line.

scientific article published on 13 October 2015

Impact of Chemotherapy-induced Menopause in Women of Childbearing Age With Non-metastatic Breast Cancer - Preliminary Results From the MENOCOR Study

scientific article published on 23 October 2018

Intraoperative imprint cytology examination of sentinel lymph nodes after neoadjuvant chemotherapy in breast cancer patients

scientific article published on 13 February 2010

Is it important to adapt neoadjuvant chemotherapy to the visible clinical response? An open randomized phase II study comparing response-guided and standard treatments in HER2-negative operable breast cancer

scientific article

Late lines of treatment benefit survival in metastatic breast cancer in current practice?

scientific article published on 17 August 2011

Mammalian target of rapamycin inhibitors in combination with letrozole in breast cancer

scientific article published on 01 October 2006

Measurement of residual disease after neoadjuvant chemotherapy

scientific article published on 01 June 2008

Metastatic breast cancer: overall survival related to successive chemotherapies. What do we gain after the third line?

scientific article published on 01 January 2009

Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact

scientific article published on 14 May 2014

Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer.

scientific article published on 28 December 2015

Neoadjuvant FEC 100 for operable breast cancer: eight-year experience at Centre Jean Perrin.

scientific article published in October 2004

Neoadjuvant endocrine therapy in breast cancer

scientific article published on 17 October 2005

Neurotoxicity as a prognostic factor in patients with metastatic breast cancer treated with ixabepilone as a first-line therapy

scientific article published on 27 November 2014

Prognostic factors in operable breast cancer treated with neoadjuvant chemotherapy: towards a quantification of residual disease.

scientific article published on 8 January 2015

Prognostic value of initial tumor parameters after metastatic relapse

scientific article published on 01 November 2011

Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation

scientific article published on 01 March 2008

Stress, cancer and circadian rhythm of melatonin

scientific article published on 20 January 2005

TERT promoter status and gene copy number gains: effect on TERT expression and association with prognosis in breast cancer

scientific article published on 24 August 2017

Temozolomide and unusual indications: review of literature.

scientific article published on 19 July 2012

The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study

scientific article

The role of tomosynthesis in breast cancer staging in 75 patients

scientific article published on 30 July 2014

Therapeutic potential of melatonin in cancer treatment

scientific article

Treatment-Induced Cardiotoxicity in Breast Cancer: A Review of the Interest of Practicing a Physical Activity

scientific article published on 03 April 2019

Weight Evolution During Endocrine Therapy for Breast Cancer in Postmenopausal Patients: Effect of Initial Fat Mass Percentage and Previous Adjuvant Treatments

scientific article published on 18 June 2018

Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse.

scientific article published on 25 November 2010

Paulina is supported by:

About Paulina

Help